Page last updated: 2024-08-25

clarithromycin and Buruli Ulcer

clarithromycin has been researched along with Buruli Ulcer in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (6.06)	29.6817
2010's	23 (69.70)	24.3611
2020's	8 (24.24)	2.80

Authors

Authors	Studies
Pluschke, G; Röltgen, K	1
Pluschke, G; Warryn, L	1
Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G	1
Chamseddine, S; Haddad, SF; Hindy, JR; Kanj, SS	1
Johnson, PDR	1
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T	1
Jerjen, R; Moodley, A; Sinclair, R	1
Abbass, A; Dzudzor, B; Gyamfi, E; Mosi, L; Narh, CA; Quaye, C	1
Guarner, J	1
Ishii, N; Richardson, M; Yotsu, RR	1
Almeida, DV; Converse, PJ; Grosset, JH; Lee, J; Li, SY; Nuermberger, EL; Omansen, TF	1
Arenaz-Callao, MP; González Del Río, R; Lucía Quintana, A; Mendoza-Losana, A; Ramón-García, S; Thompson, CJ	1
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J	1
Abass, MK; Adu, E; Agbavor, B; Ahor, H; Amoako, YA; Asiedu, K; Awuah, DO; Boakye-Yiadom, E; Danso, KG; Frimpong, M; Phillips, RO; Plange-Rhule, G; Sarpong, F; Wansbrough-Jones, M	1
Abass, KM; de Zeeuw, J; Duggirala, S; Nienhuis, WA; Omansen, TF; Stienstra, Y; Tuah, W; van der Werf, TS	1
Athan, E; Callan, P; Friedman, ND; Hughes, AJ; Khajehnoori, M; McDonald, A; O'Brien, DP; Rahdon, R	1
Abass, MK; Abotsi, J; Amoako, YA; Asiedu, K; Forson, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M; Wilson, T	1
Kingma, R; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS	1
Abass, MK; Amoako, YA; Ampadu, E; Asiedu, K; Forson, M; Frimpong, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M	1
Athan, E; Callan, P; Cowan, R; Friedman, ND; Fyfe, J; Hughes, AJ; McDonald, A; O'Brien, DP	1
Aihara, M; Ishii, N; Makigami, K; Nakanaga, K; Sugawara, M; Suzuki, K; Umebayashi, Y	1
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y	1
Athan, E; Friedman, ND; O'Brien, DP; Walton, AL	1
Aubry, A; Chauffour, A; Jarlier, V; Robert, J; Veziris, N	1
Affolabi, D; Anagonou, SY; Asiedu, K; Barogui, YT; Dossou, AD; Johnson, CR; Portaels, F; Sopoh, GE; Zohoun, T	1
Abass, KM; Adjei, O; Ampadu, EO; Awua-Boateng, NY; Awuah, PC; Bretzel, G; Nienhuis, WA; Schouten, JP; Siegmund, V; Stienstra, Y; Thompson, WA; Tuah, W; van der Werf, TS	1
Ito, Y; Kondo, M; Kurokawa, I; Mizutani, H; Yamanaka, K; Yamazaki, T	1
Billal, DS	1
Ezzedine, K; Guir, V; Malvy, D; Pistone, T	1
Adjei, O; Alffenaar, JW; Almeida, D; de Velde, F; Grosset, J; Nienhuis, WA; Uges, DR; van der Werf, TS; Wessels, AM; Zuur, AT	1
Adeye, A; Ardant, MF; Chauty, A; Cottin, J; Goundoté, A; Ji, B; Ladikpo, T; Landier, J; Marsollier, L; Pluschke, G; Ruf, T	1
Ahmad, Z; Almeida, D; Converse, PJ; Dooley, KE; Grosset, JH; Nuermberger, EL	1
Hoshino, Y; Ishii, N; Nakanaga, K; Onoe, H; Takeuchi, T; Yotsu, RR	1

Reviews

2 review(s) available for clarithromycin and Buruli Ulcer

Article	Year
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease. Journal of clinical microbiology, 2018, Volume: 56, Issue:4 Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin	2018
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). The Cochrane database of systematic reviews, 2018, 08-23, Volume: 8 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination	2018

Article

Year

Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.

Journal of clinical microbiology, 2018, Volume: 56, Issue:4

Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin

2018

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

The Cochrane database of systematic reviews, 2018, 08-23, Volume: 8

Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination

2018

Trials

4 trial(s) available for clarithromycin and Buruli Ulcer

Article	Year
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu Trials, 2022, Jul-08, Volume: 23, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome	2022
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult	2020
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet (London, England), 2010, Feb-20, Volume: 375, Issue:9715 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Ghana; Humans; Injections, Intramuscular; Leprostatic Agents; Male; Mycobacterium ulcerans; Rifampin; Statistics, Nonparametric; Streptomycin; Time Factors; Treatment Outcome; Young Adult	2010
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Antibiotics, Antitubercular; Buruli Ulcer; Chromatography, Liquid; Clarithromycin; Humans; Microbial Sensitivity Tests; Rifampin; Tandem Mass Spectrometry	2010

Other Studies

27 other study(ies) available for clarithromycin and Buruli Ulcer

Article	Year
Overview: Development of Drugs Against Mycobacterium ulcerans. Methods in molecular biology (Clifton, N.J.), 2022, Volume: 2387 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Pharmaceutical Preparations	2022
Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans. Antimicrobial agents and chemotherapy, 2022, 01-18, Volume: 66, Issue:1 Topics: Buruli Ulcer; Clarithromycin; Humans; Mycobacterium ulcerans; Oxidation-Reduction; Rifampin	2022
BMJ case reports, 2022, 08-09, Volume: 15, Issue:8 Topics: Adult; Buruli Ulcer; Clarithromycin; Humans; Lung; Male; Mycobacterium ulcerans; Rifampin	2022
Buruli ulcer: cured by 8 weeks of oral antibiotics? Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Rifampin; Streptomycin	2020
The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series. The Australasian journal of dermatology, 2020, Volume: 61, Issue:4 Topics: Adolescent; Aged; Antibiotics, Antitubercular; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Victoria	2020
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions. BMC microbiology, 2021, 01-05, Volume: 21, Issue:1 Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacillus; Bacteria; Buruli Ulcer; Candida; Clarithromycin; Coinfection; Cote d'Ivoire; Cross-Sectional Studies; Female; Fungi; Ghana; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Staphylococcus; Streptomycin; Trichoderma; Watchful Waiting; Young Adult	2021
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Oxazolidinones; Rifampin; Tetrazoles	2019
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. PLoS neglected tropical diseases, 2019, Volume: 13, Issue:1 Topics: Administration, Oral; Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Buruli Ulcer; Clarithromycin; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin	2019
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin	2019
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports. Journal of medical case reports, 2019, Jul-18, Volume: 13, Issue:1 Topics: Administration, Oral; Antibiotics, Antitubercular; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Infant, Newborn; Infectious Disease Incubation Period; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin	2019
Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. The American journal of tropical medicine and hygiene, 2013, Volume: 89, Issue:3 Topics: Anti-Bacterial Agents; Buruli Ulcer; Case-Control Studies; Clarithromycin; Female; Humans; Male; Mycobacterium ulcerans; Neopterin; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2013
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort. PLoS neglected tropical diseases, 2013, Volume: 7, Issue:7 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Cohort Studies; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Treatment Outcome	2013
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Ghana; Humans; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome	2014
Compliance with antimicrobial therapy for buruli ulcer. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin	2014
Reply to "compliance with antimicrobial therapy for buruli ulcer". Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin	2014
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients? PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antitubercular; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Withholding Treatment	2015
Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. The Journal of dermatology, 2015, Volume: 42, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Japan; Levofloxacin; Male; Middle Aged; Rifampin; Young Adult	2015
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:6 Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome	2015
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Clarithromycin; Cohort Studies; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium ulcerans; Prospective Studies; Rifampin; Victoria; Young Adult	2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:10 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Diarylquinolines; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium ulcerans; Rifampin	2016
Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin. The Medical journal of Australia, 2008, Nov-03, Volume: 189, Issue:9 Topics: Adult; Antibiotics, Antitubercular; Benin; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin Transplantation	2008
Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. International journal of dermatology, 2009, Volume: 48, Issue:12 Topics: Aged, 80 and over; Buruli Ulcer; Clarithromycin; Forearm; Granuloma, Foreign-Body; Humans; Male; Polymerase Chain Reaction; Skin Ulcer	2009
Antimicrobial drugs for Buruli ulcer. Lancet (London, England), 2010, May-29, Volume: 375, Issue:9729 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Mice; Rifampin; Streptomycin	2010
Painful Buruli ulcer in a Malian visitor to France. Acta dermato-venereologica, 2010, Volume: 90, Issue:4 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; France; Humans; Leg Ulcer; Male; Mali; Mycobacterium ulcerans; Pain; Rifampin; Travel; Treatment Outcome	2010
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-01, Volume: 52, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Pilot Projects; Rifampin; Treatment Outcome; Young Adult	2011
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice. PLoS neglected tropical diseases, 2011, Jan-04, Volume: 5, Issue:1 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Treatment Outcome	2011
Buruli ulcer accompanied by pain in a Japanese patient. The Journal of dermatology, 2012, Volume: 39, Issue:10 Topics: Anti-Bacterial Agents; Asian People; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Face; Female; Humans; Middle Aged; Mycobacterium ulcerans; Ofloxacin; Pain; Rifampin	2012